tirofiban has been researched along with Shock, Cardiogenic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhm, M; Girndt, M; Link, A; Rbah, R; Selejan, S | 1 |
| Bosković, A; Dragnić, S; Knezević, B; Musić, L; Nikolić, G | 1 |
| Jörres, A; Storm, C | 1 |
| Erden, I; Ordu, S; Ozhan, H | 1 |
| Akkus, MN; Aytacoğlu, B; Camsari, A; Cicek, D; Cin, VG; Doven, O; Kanik, A; Katircibasi, MT; Pekdemir, H; Sucu, N | 1 |
1 trial(s) available for tirofiban and Shock, Cardiogenic
| Article | Year |
|---|---|
Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Blood Platelets; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Count; Prospective Studies; Renal Replacement Therapy; Shock, Cardiogenic; Tirofiban; Tyrosine | 2008 |
4 other study(ies) available for tirofiban and Shock, Cardiogenic
| Article | Year |
|---|---|
Successful treatment of cardiogenic shock by stenting of the left main coronary artery in acute myocardial infarction.
Topics: Coronary Vessels; Electrocardiography; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Stents; Thrombolytic Therapy; Tirofiban; Tyrosine | 2008 |
Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy?
Topics: Blood Platelets; Critical Care; Humans; Platelet Count; Renal Replacement Therapy; Shock, Cardiogenic; Tirofiban; Treatment Outcome; Tyrosine | 2008 |
A case of acute stent thrombosis treated successfully with intracoronary tirofiban.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Equipment Failure Analysis; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Male; Middle Aged; Shock, Cardiogenic; Stents; Tirofiban; Tyrosine | 2010 |
Impact of invasive strategy for the management of patients with cardiogenic shock after acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Chemotherapy, Adjuvant; Coronary Artery Bypass; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Risk Factors; Shock, Cardiogenic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Tyrosine | 2004 |